Dwi Gayatri

Dwi Gayatri

Auto-generated profile, based on publicly available information

Dwi Gayatri

Faculty of Public Health Universitas Indonesia, West Java, Indonesia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2020 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
DGDwi Gayatri
Dwi Gayatri
LELjupcho Efremov
Ljupcho Efremov
EKEva Johanna Kantelhardt
Eva Johanna Kantelhardt
RMRafael Mikolajczyk
Rafael Mikolajczyk
Purpose: This systematic review aims to summarize factors that influence the quality of life (QOL) of advanced cancer patients in palliative care (PC) in developing countries. Understanding this context in developing countries milieu is necessary; however, this outcome is rarely reported. Methods: Following the PRISMA guidelines, the electronic databases MEDLINE, Embase, CINAHL, and Web of Science were systematically searched using the search terms: QOL, cancer, PC, and names of all developing countries. Studies with less than ten subjects, qualitative or pilot studies, reviews, conference abstracts, and that reported validation of QOL questionnaires were excluded. Results: Fifty-five studies from 15 developing countries in the African (n = 5), Latin America and the Caribbean (n = 10), and Asian (n = 40) region were included in the narrative synthesis. 65.4% were cross-sectional, 27.3% were cohort studies, 7.3% were RCTs or quasi-experimental studies. Around 30 QOL factors were studied with 20 different types of QOL instruments. Advanced cancer patients who were older, married/ever married, participated in additional care within PC, used complementary and alternative medicine (CAM), and practiced spirituality/religiosity showed higher QOL score. Low educational level and high depression were associated with a lower QOL. Conclusion: Various factors affect QOL among cancer patients in PC. Patients valued the use of CAMs; however, the quality and safety aspects should be properly addressed. Important factors that influenced the QOL score were social and spiritual support. While there is a general need to develop PC strategies further, recognizing patients’ needs should be prioritized in national cancer programs.

1 September 2021 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
DGDwi Gayatri
Dwi Gayatri
LELjupcho Efremov
Ljupcho Efremov
RMRafael Mikolajczyk
Rafael Mikolajczyk
EKEva Johanna Kantelhardt
Eva Johanna Kantelhardt
Purpose: Studies assessing quality of life (QOL) in palliative care settings are still scarce. We assessed the QOL score and pain severity in advanced breast cancer patients at the National Cancer Hospital in Indonesia and associations between QOL domains with QOL and pain scores. Materials and Methods: A total of 160 patients who met the study inclusion criteria (female, > 18 years old, diagnosed with stage III or IV breast cancer) answered the European Organization for Research and Treatment of Cancer QOL questionnaire (EORTC QLQ-C15-PAL) and the visual analogue scale (VAS) tool for pain severity, prior to palliative oncology treatment. Additionally, several sociodemographic and clinical characteristics were collected. Linear regression models, adjusted for age, the Karnofsky Performance Status (KPS) score, and specific QOL domains were used to explore the associations between the global QOL and VAS scores with the different QOL domains. Results: The patients had a mean age of 50 years (range: 29– 76). The overall score for QOL and score for VAS was (mean ± SD) 78.02 ± 15.34 and 2.1 ± 2.4, respectively. The analysis demonstrated that the domains of emotional functioning (effect estimate: 0.25; 95% CI: 0.14 to 0.37), fatigue (− 0.21; − 0.33 to − 0.09), pain (− 0.13; − 0.25 to − 0.01), insomnia (− 0.25; − 0.37 to − 0.13), and appetite loss (− 0.13; − 0.25 to − 0.008) were associated with the QOL score. Only the KPS score (− 0.28; − 0.46 to − 0.11) was associated with the VAS score. Conclusion: Our study showed high QOL and low VAS scores in advanced breast cancer patients prior to palliative oncology treatment. Several QOL domains (emotional functioning, fatigue, pain, insomnia, and appetite loss) were associated with QOL and the KPS was associated with the pain score. Therefore, these specific QOL domains should be given priority in improving QOL in this patient group.

9 June 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EBErlina Burhan
Erlina Burhan
FAFarchan Azzumar
Farchan Azzumar
FSFira Alyssa Gabriella Sinuraya
Fira Alyssa Gabriella Sinuraya
SPSabarinah Prasetyo
Sabarinah Prasetyo
DGDwi Gayatri
Dwi Gayatri
EWElvan Wiyarta
Elvan Wiyarta
Background: Vaccination was included in the Indonesian government policy to address Delta and Omicron waves of SAR-CoV-2 infections. This study assesses the effectiveness of inactivated (CoronaVac, BBIBP-Cor) and mRNA vaccines (mRNA-1273, BNT162b2) against COVID-19 regardless of symptoms and fatal COVID-19 (mortality within 30 days after confirmed RT-PCR) during Delta and Omicron period in Jakarta, Indonesia. Methods: This study case-control, test-negative study included all individuals aged over 18 years in Jakarta with complete and consistent SARS-CoV-2 RT-PCR results from 1 June to 31 August 2021 (Delta period) and 1 January to 2 April 2022 (Omicron period), as well as complete vaccination status. This study integrates several public health data from the Jakarta provincial government. From the odds ratio, vaccine effectiveness (VE) was analyzed as the primary outcome using unmatched analysis, matched analysis, and adjustments for other factors. Results: This study includes 982,885 eligible subjects recorded from March 2021 to April 2022. All subjects generally underwent testing 4–9 weeks after their last vaccine dose. The VE of 2-dose inactivated vaccine against SARS-CoV-2 infection during Delta wave was 22.06% (95% CI 20.63–24.54) and the VE against fatal COVID-19 was 78.55% (95% CI 72.91–83.00). A complete primary dose of mRNA vaccine showed VE of 24.81% (95% CI 16.81–32.09) against infection during Omicron wave. Furthermore an additional mRNA booster dose showed VE of 68.82% (95% CI 54.11–78.82) based on unmatched analysis. Conclusion: A complete primary dose of inactivated vaccine provided mild protection against COVID-19 and essential protection against fatal cases during the Delta wave, but offered little to no protection during the Omicron wave. In contrast, the mRNA vaccine, either as primary vaccination, homologous, or heterologous booster regimen, conferred acceptable protection against Omicron. This study recommends real-world vaccination strategies for LMICs with typical vaccine supply constraints.

30 November 2023 in Journal of Preventive Medicine and Public Health
Verified
Journal Article
Open access
PDF file
HHHotma Martogi Lorensi Hutapea
Hotma Martogi Lorensi Hutapea
PDPandji Dhewantara
Pandji Dhewantara
ASAnton Suryatma
Anton Suryatma
RARaras Anasi
Raras Anasi
HHHarimat Hendarwan
Harimat Hendarwan
DGDwi Gayatri
Dwi Gayatri
Objectives: Prospective studies on vaccination status and mortality related to coronavirus disease 2019 (COVID-19) in low-resource settings are still limited. We assessed the association between vaccination status (full, partial, or none) and in-hospital mortality among COVID-19 patients at most hospitals in Jakarta, Indonesia during the Delta predomination wave.Methods: We conducted a retrospective cohort study among hospitalized COVID-19 patients who met the study criteria (>18 years old and admitted for inpatient treatment because of laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection). We linked individual-level data in the hospital admission database with vaccination records. Several socio-demographic and clinical characteristics were also analyzed. A Cox proportional hazards regression model was used to explore the association between vaccination status and in-hospital mortality in this patient group.Results: In total, 40 827 patients were included in this study. Of these, 70% were unvaccinated (n=28 543) and 19.3% (n=7882) died during hospitalization. The mean age of the patients was 49 years (range, 35-59), 53.2% were female, 22.0% had hypertension, and 14.2% were treated in the intensive care unit, and the median hospital length of stay across the group was 9 days. Our study showed that the risk of in-hospital mortality among fully and partially vaccinated patients was lower than among unvaccinated adults (adjusted hazard ratio [aHR], 0.43; 95% confidence interval [CI], 0.40 to 0.47 and aHR, 0.70; 95% CI, 0.64 to 0.77, respectively).Conclusions: Vaccinated patients had fewer severe outcomes among hospitalized adults during the Delta wave in Jakarta. These features should be carefully considered by healthcare professionals in treating adults within this patient group.